Human Leukocyte Immunoglobulin-Like Receptor Subfamily A Member 2 (LILRA2) Protein

Este producto es parte de LILRA2 - leukocyte immunoglobulin like receptor A2
Product Graph
273€ (10 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Human Leukocyte Immunoglobulin-Like Receptor Subfamily A Member 2 (LILRA2) Protein
category
Proteins and Peptides
provider
Abbexa
reference
abx690595
tested applications
SDS-PAGE

Description

Leukocyte Immunoglobulin-Like Receptor Subfamily A Member 2 (LILRA2) protein is a recombinant Human protein expressed in HEK293 cells.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Proteins and Peptides
Immunogen Target
Leukocyte Immunoglobulin-Like Receptor Subfamily A Member 2 (LILRA2)
Host
HEK293 cells
Assay Type
Activity: Not tested
Sequence Fragment: Gly24-Ser420
Tag: C-terminal 6 His tag
Origin
Human
Observed MW
Calculated MW: 44.8 kDa  Observed MW (SDS-PAGE): 66 kDa
Expression
Recombinant
Purity
> 95% (SDS-PAGE)
Purification
0.2 µm filtered prior to lyophilization.
Size 1
10 µg
Size 2
50 µg
Form
Lyophilized
Tested Applications
SDS-PAGE
Buffer
Prior to lyophilization: 20 mM PBS,150 mM NaCl,pH 7.4, containing 5%-8% Trehalose, Mannitol and 0.01% Tween 80.
Availability
Shipped within 5-15 working days.
Storage
Storage: Store lyophilized between -20 °C and -80°C.
Stability: Stable when stored reconstituted at 2-8°C for up to 1 week. Reconstituted aliquots are stable at -20°C for up to 3 months.
Shelf Life: 12 months.
Dry Ice
No
UniProt ID
Q8N149
Gene ID
11027
OMIM
604812
Alias
Leukocyte immunoglobulin-like receptor subfamily A member 2,ILT1,LIR7,CD85H,LIR-7,Immunoglobulin-like transcript 1,Leukocyte immunoglobulin-like receptor 7
Background
Protein LILRA2
Status
RUO
Note
THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION.
Reconstitute in sterile H2O to prepare a stock solution of concentration 0.25 mg/ml. Do not vortex.
Endotoxin Level: < 1.0 EU per µg (LAL method).

Descripción

LILRA2, also known as Leukocyte Immunoglobulin-Like Receptor A2 (LILRA2) or CD85h, is a member of the immunoglobulin superfamily and part of the leukocyte immunoglobulin-like receptor (LILR) family. This receptor is encoded by the LILR gene cluster on chromosome 19q13.4, which is home to various immunoglobulin-like receptors involved in immune regulation. LILRA2 plays an activating role in immune response modulation and is predominantly expressed on monocytes, macrophages, and some other leukocyte subsets, such as granulocytes. It is essential in host defense, participating in immune responses to infections and modulating inflammation through cellular signaling pathways. The receptor interacts with a variety of ligands, likely including MHC class I molecules, which allows it to influence both innate and adaptive immunity. The immune-modulating role of LILRA2 makes it an essential subject of study in the context of immune responses and inflammation. Unlike other LILR members that may provide inhibitory signaling, LILRA2 is classified as an activating receptor, generally enhancing immune responses through its interaction with signaling adaptors that contain immunoreceptor tyrosine-based activation motifs (ITAMs). This activating function of LILRA2 contrasts with some members of the LILRB subfamily, which contain immunoreceptor tyrosine-based inhibitory motifs (ITIMs) and thus help suppress immune responses. Research has shown that aberrant expression or dysregulation of LILRA2 can contribute to inflammatory diseases, autoimmunity, and potentially cancer, making it a focal point for therapeutic interventions.

Related Products

EH2451

Human LILRA2 (Leukocyte immunoglobulin-like receptor subfamily A member 2) ELISA Kit

Ver Producto
FNab04775

LILRA2 antibody

Does not bind class I MHC antigens.

Ver Producto
Pr23027

Recombinant Human LILRA2

Ver Producto